DGAP-News: PNE WIND AG sells the Sontra und Kemberg III

New Post Public Reply Private Reply Replies (0) Message Board

News Desk 2018

Jul 31, 2014 at 4:30 AM

DGAP-News: PNE WIND AG sells the Sontra und Kemberg III wind farms to CHORUS

DGAP-News: PNE WIND AG / Key word(s): Miscellaneous PNE WIND AG sells the Sontra und Kemberg III wind farms to CHORUS 31.07.2014 / 10:28 --------------------------------------------------------------------- Cuxhaven, 31 July 2014 - The wind farm project developer, PNE WIND AG, has sold the two wind farms, "Sontra" (Hessen) and "Kemberg III" (Sachsen-Anhalt), to a Luxemburg special fund administered by the CHORUS Group. The wind farms with a total of nine wind energy systems have a combined nominal output of 21.6 MW. Both wind farms were developed by PNE WIND AG and upon completion, the company will be responsible for the technical operations management. Both wind farms are currently under construction and will be completed and commissioned in the second half of 2014. The Nordex N117 wind energy systems demonstrate a particularly high efficiency in inland locations with the systems benefitting from high hub heights which reach 140.6 metres. This allows for the optimum harnessing of the wind at both locations and thus ensures that the new wind energy systems can produce environmentally friendly electricity which is equivalent to the annual consumption of about 18,000 four person households. The CHORUS Group has purchased wind farms developed and constructed by PNE WIND AG for the first time. "We are delighted to have been able to purchase these wind farms equipped with the most modern of turbines from such a professional developer as PNE WIND AG and look forward with pleasure to a long term co-operation both in their technical operations management as well as in further projects" said Holger GÃ¶tze, responsible for investment in the CHORUS Group's business management. Martin Billhardt, Chairman (CEO) of PNE WIND AGs Board of Directors: "We are very pleased that CHORUS has now chosen wind farms developed by us for the first time. Considering the long term nature of the investment, this demonstrates trust placed in the wind farms developed by our team. We would be very pleased if this co-operation could also be continued in the future". Company profiles PNE WIND AG With its headquarters in Cuxhaven, the PNE WIND - Group plans and realises wind farm projects on land (onshore) and on the high seas (offshore). In so doing, its core competence lies in the development, project planning, realisation and financing of wind farms with the subsequent provision of service. To date, the PNE Wind Group has already successfully developed wind farms with a total nominal output amounting to some 2,000 MW. In addition to its business activities in the established German home market, PNE WIND AG is expanding into dynamic growth markets and is already represented through joint ventures and subsidiary companies in 14 countries in Europe, Africa and North America. In these countries wind farm projects with a nominal output of approximately 4,800 MW are currently being developed and are planned to be completed in the medium term. In addition, PNE WIND AG is developing offshore wind farm projects, of which four major projects in German waters have already been approved. About CHORUS The CHORUS Group was founded in the year 1998 and has been providing investors with investment opportunities exclusively in plants for the production of renewable energies since 2006. More than 100 solar and wind power plants in five European countries have been realised since that time. The company currently administers a portfolio of wind and solar energy farms with a combined nominal output of over 220 MW. The CHORUS Group covers the entire investment cycle of a plant - from asset sourcing to the economic and legal Due Diligence and monitoring right through to its sale. Here, CHORUS has proven its competence: As at 31st December 2013 the average return on the entire portfolio was 6.9 percent p.a. Contact: Contact: PNE WIND AG Rainer Heinsohn Head of Corporate Communication Tel: +49(0) 47 21 - 7 18 - 453 Fax: +49(0) 47 21 - 7 18 - 373 E-mail: Rainer.Heinsohn@pnewind.com PNE WIND AG Investor Relations Scott McCollister Tel: +49(0) 47 21 - 7 18 - 454 Fax: +49(0) 47 21 - 7 18 - 373 E-mail: Scott.McCollister@pnewind.com Investor Relations cometis AG Ulrich Wiehle / Janis Fischer Tel: +49(0) 611 - 205855-64 Fax: +49(0) 611 - 205855-66 E-mail: fischer@cometis.de --------------------------------------------------------------------- 31.07.2014 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: PNE WIND AG Peter-Henlein-StraÃe 2-4 27472 Cuxhaven Germany Phone: 04721 / 718 - 06 Fax: 04721 / 718 - 200 E-mail: info@pnewind.com Internet: http://www.pnewind.com ISIN: DE000A0JBPG2, DE000A0B9VG7, , DE000A1EMCW3, , DE000A0Z1MR2, , DE000A1R0741 WKN: A0JBPG, A0B9VG, , A1EMCW, , A0Z1MR, , A1R074 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Berlin, DÃ¼sseldorf, Hamburg, MÃ¼nchen, Stuttgart End of News DGAP News-Service --------------------------------------------------------------------- 280183 31.07.2014

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

2026 Community Impact Week: Slam Dunk for Community Unity

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

LEGO Mashes Star Wars and Marvel for Fans' Delight

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Pacira BioSciences Faces Shareholder Revolt in M&A Deal

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Southern Company Sparks Swift Power Restoration Post-Isaias

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

AI Drives Major Time Savings in Endoscopy Tech

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...